What If I Want to Switch Between GLP-1 Medication Brands?
Learn how to safely switch between GLP-1 medications like semaglutide, tirzepatide, and retatrutide, including timing, dosing, and what to expect during the transition.
More on What If Questions
Important Medical Disclaimer
This article is for informational purposes only. Never switch medications without your prescribing provider's guidance. Dose equivalencies between GLP-1 medications are not straightforward.
The Direct Answer
Switching between GLP-1 medications is common, safe, and straightforward when done under medical supervision. The most common switch is from semaglutide to tirzepatide (or vice versa), typically to break a weight loss plateau or manage side effects.
The key principle: always start the new medication at its lowest dose, regardless of what dose you were on with the previous medication. Different GLP-1 medications have different potencies and side effect profiles, and there is no direct dose conversion between them.
Expect a 4-8 week adjustment period during which you re-titrate the new medication. Some temporary side effects may return as your body adjusts to the new drug's pharmacology.
Common Switch Scenarios
Semaglutide to Tirzepatide
The most popular switch. Tirzepatide's dual GIP/GLP-1 mechanism often produces additional weight loss. Take last semaglutide dose, wait one week, start tirzepatide at 2.5mg. Trimi offers compounded tirzepatide at $125/mo.
Tirzepatide to Semaglutide
Usually done for cost savings or side effect management. Take last tirzepatide dose, wait one week, start semaglutide at the lowest dose. Trimi offers compounded semaglutide at $99/mo.
Brand Name to Compounded
Switching from Ozempic/Wegovy to compounded semaglutide, or Mounjaro/Zepbound to compounded tirzepatide. Same active ingredient, significant cost savings. Your provider matches the dose directly.
Either to Retatrutide
The newest option with triple receptor activity (GLP-1/GIP/glucagon). Start at the lowest dose. Early data shows potentially greater weight loss than either semaglutide or tirzepatide alone.
What to Expect During the Switch
Temporary Weight Fluctuation
You may gain 2-5 pounds during the transition as the old medication clears and the new one titrates up. This is normal and temporary.
New Side Effect Profile
Even if you tolerated one GLP-1 well, you may experience different side effects with another. Tirzepatide users sometimes report less nausea but more constipation compared to semaglutide.
Re-Titration Period
Plan for 4-8 weeks of dose escalation with the new medication. Full weight loss effect may take 2-3 months to reach peak levels.
Frequently Asked Questions
Why would I switch GLP-1 medications?
Common reasons include: weight loss plateau on current medication, intolerable side effects, cost considerations, wanting greater efficacy (e.g., switching from semaglutide to tirzepatide for potentially greater weight loss), supply/availability issues, or wanting to try a newer option like retatrutide.
How do I switch from semaglutide to tirzepatide?
Your provider will typically have you take your last semaglutide dose, wait one week (your normal injection interval), then start tirzepatide at a low dose (2.5mg). You do not need a washout period since both are weekly injections. Expect a new titration phase with potentially different side effects.
Will I regain weight during a medication switch?
Brief regain is possible during the transition as the old medication clears and the new one is titrated up. This is usually 2-5 pounds of water and food weight, not fat regain. Once the new medication reaches therapeutic levels, weight loss typically resumes.
Do I start at the lowest dose when switching?
Yes, most providers recommend starting the new medication at the lowest dose regardless of what dose you were on previously. This reduces the risk of severe side effects from the new medication and allows your body to adjust to its different pharmacological profile.
Can I switch from brand name to compounded GLP-1 medications?
Yes. Many patients switch from brand-name Ozempic or Mounjaro to compounded semaglutide ($125/mo at Trimi) or compounded tirzepatide ($125/mo at Trimi) for significant cost savings. The active ingredient is the same. Your provider will help with the transition.
Ready to Switch or Start GLP-1 Therapy?
Our providers guide medication transitions for optimal results. Semaglutide from $99/mo, tirzepatide from $125/mo, plus retatrutide.
Explore Treatment OptionsSources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).